Journals / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 6

Hemostatic effects of adrenaline and Ankaferd (blood stopper) during orthodontic attachment bonding

Pages
1234–1238
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The bleedingperiod was recorded as the time from the exposure of the crown until the inception of bonding.Results: It was observed that both the bleeding period and the cumulative duration were significantly shorter in group B (the ABSgroup) than in group A (the adrenaline group) (P < 0.05), but no significant deviation in bonding times was recorded.Conclusion: ABS is a good alternative hemostatic agent for the prevention of bleeding at the surgical exposure of impacted teethwithout affecting the bonding.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Moisture prevention during the bonding of orthodontic attachments on impacted teeth is crucial for accomplishment.It was aimed to compare the hemostatic effects of adrenaline and Ankaferd Blood Stopper (ABS) during the surgical exposure of theimpacted maxillary canine.Materials and methods: The study consists of 20 patients, whose orthodontic treatments were outlined with the surgical exposure ofmaxillary impacted canine.
📊
Key Findings & Data:Patients were divided into groups of 10; where each group was treated with one of the two medicines tocontrol bleeding.
💡
Conclusion & Impact:The bleedingperiod was recorded as the time from the exposure of the crown until the inception of bonding.Results: It was observed that both the bleeding period and the cumulative duration were significantly shorter in group B (the ABSgroup) than in group A (the adrenaline group) (P < 0.05), but no significant deviation in bonding times was recorded.Conclusion: ABS is a good alternative hemostatic agent for the prevention of bleeding at the surgical exposure of impacted teethwithout affecting the bonding.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Moisture prevention during the bonding of orthodontic attachments on impacted teeth is crucial for accomplishment.It was aimed to compare the hemostatic effects of adrenaline and Ankaferd Blood Stopper (ABS) during the surgical exposure of theimpacted maxillary canine.Materials and methods: The study consists of 20 patients, whose orthodontic treatments were outlined with the surgical exposure ofmaxillary impacted canine. Patients were divided into groups of 10; where each group was treated with one of the two medicines tocontrol bleeding. Group A was treated with adrenaline, and group B was treated with Ankaferd Blood Stopper (ABS). The bleedingperiod was recorded as the time from the exposure of the crown until the inception of bonding.Results: It was observed that both the bleeding period and the cumulative duration were significantly shorter in group B (the ABSgroup) than in group A (the adrenaline group) (P < 0.05), but no significant deviation in bonding times was recorded.Conclusion: ABS is a good alternative hemostatic agent for the prevention of bleeding at the surgical exposure of impacted teethwithout affecting the bonding.

🔖

Cite This Article

ÖZ, A. Z., AKTAŞ, A., EL, H., ADİLOĞLU, S. (2022). Hemostatic effects of adrenaline and Ankaferd (blood stopper) during orthodontic attachment bonding. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 6, 1234–1238. https://ajindex.com/articles/610360

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Sayinsu K, Isik F, Sezen S, Aydemir B. Effect of blood and saliva contamination on bond strength of brackets bonded with a protective liquid polish and a light-cured adhesive. Am J Orthod Dentofac 2007; 131(3): 391-394.
  2. Okşayan R, Sökücü O, İşman NE, Kayali KM, Cebe MA. Effects of hemostatic agents on shear bond strength of orthodontic brackets. Niger J Clin Pract 2015; 18(2): 189-193.
  3. Karabekiroğlu S, Kök H. Do hemostatic agents affect shear bond strength and clinical bond failure rate of orthodontic brackets? J Adhes Sci Technol 2017; 32: 103-113.
  4. Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 2010; 251: 217-228.
  5. Von Arx T, Jensen SS, Hänni S, Schenk RK. Haemostatic agents used in periradicular surgery: an experimental study of their efficacy and tissue reactions. Int Endod J 2006; 39: 800-808.
  6. Loescher AR, Robinson PP. The effect of surgical medicaments on peripheral nerve function. Brit J Oral Max Surg 1998; 36: 327-332.
  7. Pampu AA, Yildirim M, Tüzüner T, Baygin Ö, Abidin I, Dayisoylu EH, Senel FÇ. Comparison of the effects of new folkloric hemostatic agent on peripheral nerve function: an electrophysiologic study in rats. Or Surg Or Med Or Pa 2013; 115: e1-6. Goker H, Haznedaroglu IC, Ercetin S, Kirazli S, Akman U, Ozturk Y, Firat HC. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008; 36: 163-170.
  8. İşler SC, Demircan S, Çakarer S, Çebi Z, Keskin C, Soluk M, Yüzbaşıoğlu E. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci 2010; 18: 409-414.
  9. Haznedaroglu BZ, Haznedaroglu IC, Walker SL, Bilgili H, Goker H, Kosar A, Aktas A, Captug O, Kurt M, Özdemir O et al. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clin Appl Thromb-Hem 2010; 16: 446-453.
  10. Mihmanli A, Ulker Z, Alpsoy L, Ezirganli S. Evaluation of cytotoxicity of a new hemostatic agent Ankaferd Blood Stopper® using different assays. Hum Exp Toxicol 2012; 31: 780-787.
  11. Bilgili H, Captug O, Kosar A, Kurt M, Kekilli M, Shorbagi A, Kurt OK, Ozdemir O, Goker H, Haznedaroglu IC. Oral systemic administration of Ankaferd blood stopper has no short-term toxicity in an in vivo rabbit experimental model. Clin Appl Thromb-Hem 2010; 16: 533-536.
  12. Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemost